Not applicableWithdrawnNCT01695057
What this trial is testing
Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer
Who this might be right for
Stage II Breast CancerStage IIIA Breast CancerTriple-negative Breast Cancer
University of Southern California